What significance should we attribute to the detection of MLL fusion transcripts?

Blood. 1998 Aug 1;92(3):709-11.
No abstract available

Publication types

  • Comment
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Biomarkers, Tumor / analysis*
  • Bone Marrow / chemistry*
  • Bone Marrow / embryology
  • Bone Marrow Examination
  • Bone Marrow Transplantation
  • Child
  • Child, Preschool
  • Fetal Proteins / analysis
  • Humans
  • Infant
  • Leukemia / genetics*
  • Leukemia / metabolism
  • Leukemia / mortality
  • Leukemia / therapy
  • Liver / chemistry
  • Liver / embryology
  • Mass Screening
  • Myeloid-Lymphoid Leukemia Protein
  • Neoplasm, Residual
  • Neoplasms, Second Primary / genetics
  • Neoplasms, Second Primary / metabolism
  • Neoplasms, Second Primary / mortality
  • Neoplasms, Second Primary / therapy
  • Oncogene Proteins, Fusion / analysis*
  • Oncogene Proteins, Fusion / genetics*
  • Polymerase Chain Reaction
  • Practice Patterns, Physicians'
  • Prognosis
  • RNA, Messenger / analysis*
  • RNA, Messenger / genetics
  • RNA, Neoplasm / analysis*
  • RNA, Neoplasm / genetics
  • Sensitivity and Specificity
  • Translocation, Genetic / genetics*

Substances

  • Biomarkers, Tumor
  • Fetal Proteins
  • MLL-AF4 fusion protein, human
  • Oncogene Proteins, Fusion
  • RNA, Messenger
  • RNA, Neoplasm
  • Myeloid-Lymphoid Leukemia Protein